Sign In
Buy CMPS
$12.69
-0.640 (-4.80%)
At Close: Jun 03, 2026
3 Psychedelics Stocks Getting High Thanks to the Newly Launched PSY ETF
05:22pm, Tuesday, 15'th Jun 2021
These psychedelic stocks have compelling product pipelines and have built up a great head of steam in the past month thanks to the PSY ETF. The post 3 Psychedelics Stocks Getting High Thanks to the Ne
Compass Pathways: Huge Growth Potential, But I'm Cautious
06:17am, Friday, 04'th Jun 2021
COMPASS Pathways is a business that is trying to treat a serious form of depression by using psilocybin, which is known for its psychoactive effects.
COMPASS Pathways and Kings College London publish cognition results from COMP360 psilocybin study in healthy volunteers
09:27am, Thursday, 03'rd Jun 2021
LONDON, June 03, 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in men
Is Compass Pathways a Buy?
07:07pm, Tuesday, 25'th May 2021
The biotech is developing a treatment paradigm combining talk therapy with a purified version of psilocybin, the active ingredient in "magic mushrooms." Will this be a money-maker?
Compass Pathways Offers Chance on Exploratory Mental Health Treatments
05:35am, Tuesday, 18'th May 2021
Over the past year, CMPS stock has been going nowhere fast. However, there's been recent progress in advancing psilocybin-assisted therapy.
COMPASS Pathways plc to announce first quarter 2021 financial results on 13 May 2021
08:00am, Thursday, 06'th May 2021
London, UK, May 06, 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, a
COMPASS Pathways announces pricing of public offering
08:45pm, Thursday, 29'th Apr 2021
London, UK, 30 April 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in
5 Top Medical Services Stocks to Beat COVID-Led Industry Challenges
11:32am, Wednesday, 28'th Apr 2021
5 Top Medical Services Stocks to Beat COVID-Led Industry Challenges
COMPASS Pathways launches proposed public offering
05:22pm, Tuesday, 27'th Apr 2021
London, UK, April 27, 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation i
If You Missed the Cannabis Stock Gold Rush, Try This New Industry Instead
06:40am, Saturday, 24'th Apr 2021
Magic mushrooms and other hallucinogens are becoming a big business.
Psychedelic Stocks: Atai Life Sciences IPO Seeks To Raise $100 Million
11:40am, Wednesday, 21'st Apr 2021
Atai Life Sciences hopes to raise $100 million in an initial public offering, as other psychedelic stocks seek investor cash. The post Psychedelic Stocks: Atai Life Sciences IPO Seeks To Raise $100 Mi
3 of the Top Psychedelic Stocks That Will Blow Your Mind
07:23am, Tuesday, 20'th Apr 2021
These psychedelic stocks are the sector's needle-movers and have the potential to make a big splash this year The post 3 of the Top Psychedelic Stocks That Will Blow Your Mind appeared first on Invest
3 of the Top Psychedelic Stocks That Will Blow Your Mind
07:21am, Tuesday, 20'th Apr 2021
These psychedelic stocks are the sector's needle-movers and have the potential to make a big splash this year The post 3 of the Top Psychedelic Stocks That Will Blow Your Mind appeared first on Invest
Study concludes that psilocybin findings should be explored further in larger studies Study concludes that psilocybin findings should be explored further in larger studies
COMPASS Pathways plc to participate in 20th Annual Needham Virtual Healthcare Conference
07:00am, Friday, 09'th Apr 2021
London, UK, April 09, 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health,
